Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for ESSA Pharma Inc. Common Shares (EPIX).
- Disclosed ownership: 4%.
- Date of event: 30 Sep 2025.
MORGAN STANLEY - 30 Sep 2025 SCHEDULE 13G/A Report for ESSA Pharma Inc. Common Shares (EPIX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Security
- ESSA Pharma Inc. Common Shares
- Symbol
- EPIX
- Shares outstanding
- 47,601,550 shares
- Disclosed Ownership
- 1,904,062 shares
- Ownership
- 4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Oct 2025, 16:12:52 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 4% ownership in ESSA Pharma Inc. Common Shares (EPIX) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Oct 2025, 16:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 4% | 1,904,062 | 0 | 1,876,562 | Chris O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley & Co. LLC | 0% | 0 | 0 | 0 | Chris O'Hara | Authorized Signatory, Morgan Stanley & Co. LLC |